AAVantgarde Bio
7 known investors
Find your way into AAVantgarde Bio
Sign up to see every warm intro you have to AAVantgarde Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AAVantgarde Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Clinical-stage gene therapy company developing AAV therapeutics for inherited retinal disorders.
Investors · 7
How we know: Longwood Fund's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Neva Sgr.'s portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Sixty Degree Capital's portfolio page · Not right? Tell us
How we know: Sofinnova Partners's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: XGEN Venture's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does AAVantgarde Bio do?
- Clinical-stage gene therapy company developing AAV therapeutics for inherited retinal disorders.
- Who are AAVantgarde Bio's investors?
- AAVantgarde Bio's investors include Longwood Fund, Neva Sgr., Sixty Degree Capital, Sofinnova Partners, XGEN Venture, Atlas Venture, Forbion.


